The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Open accessAbstract
OBJECTIVE: Accumulating evidence links the intestinal microbiota and colorectal carcinogenesis. Fusobacterium nucleatum may promote colorectal tumour growth and inhibit T cell-mediated immune responses against colorectal tumours. Thus, we hypothesised that the amount of F. nucleatum in colorectal carcinoma might be associated with worse clinical outcome. DESIGN: We used molecular pathological epidemiology database of 1069 rectal and colon cancer cases in the Nurses' Health Study and the Health Professionals Follow-up Study, and measured F. nucleatum DNA in carcinoma tissue. Cox proportional hazards model was used to compute hazard ratio (HR), controlling for potential confounders, including microsatellite instability (MSI, mismatch repair deficiency), CpG island methylator phenotype (CIMP), KRAS, BRAF, and PIK3CA mutations, and LINE-1 hypomethylation (low-level methylation). RESULTS: Compared with F. nucleatum-negative cases, multivariable HRs (95% CI) for colorectal cancer-specific mortality in F. nucleatum-low cases and F. nucleatum-high cases were 1.25 (0.82 to 1.92) and 1.58 (1.04 to 2.39), respectively, (p for trend=0.020). The amount of F. nucleatum was associated with MSI-high (multivariable odd ratio (OR), 5.22; 95% CI 2.86 to 9.55) independent of CIMP and BRAF mutation status, whereas CIMP and BRAF mutation were associated with F. nucleatum only in univariate analyses (p<0.001) but not in multivariate analysis that adjusted for MSI status. CONCLUSIONS: The amount of F. nucleatum DNA in colorectal cancer tissue is associated with shorter survival, and may potentially serve as a prognostic biomarker. Our data may have implications in developing cancer prevention and treatment strategies through targeting GI microflora by diet, probiotics and antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies, of multiple cohorts, of patients with CRC worldwide have found similar associations.23–27”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Self-citationRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Self-citationGur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490
Self-citationLong-term colorectal-cancer incidence and mortality after lower endoscopy
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301969 · Cited by 1,483
Self-citationGarrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Self-citationSystemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,080
Self-citationSystemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Cited by
Sorted by citations
Items 201–300 of 1,000
Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
Zhang, S., Cai, S., & Ma, Y. (2018) · Journal of Cancer · doi:10.7150/jca.24048 · Cited by 77
Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma
Shi, C., Li, Z., Zheng, J., 孔为民, Fan, T., Jian, D., Cheng, X., Zhao, H., Ma, J., Tang, H., et al. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02352-6 · Cited by 74
From Microbiome to Inflammation: The Key Drivers of Cervical Cancer
Zhou, Z., Long, H., Cheng, Y., Luo, H., Wen, D., & Gao, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.767931 · Cited by 79
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
Ye, C., Liu, X., Liu, Z., Pan, C., Zhang, X., Zhao, Z., & Sun, H. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2306676 · Cited by 76
Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy
Longhi, G., van Sinderen, D., Ventura, M., & Turroni, F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575072 · Cited by 72
Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents
Garrido-Navas, M. C., de Miguel‐Pérez, D., Expósito‐Hernández, J., Bayarri, C., Amezcua, V., Palomo, A. O., Valdivia, J., Guerrero, R., Puche, J. L. G., Lorente, J. A., et al. (2019) · Cells · doi:10.3390/cells8111382 · Cited by 73
Therapeutic Targeting of the Colorectal Tumor Stroma
Fridman, W. H., Miller, I. S., Sautès‐Fridman, C., & Byrne, A. T. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.09.045 · Cited by 72
Liu, X., Cheng, Y., Shao, L., & Ling, Z. (2020) · BioMed Research International · doi:10.1155/2020/2948282 · Cited by 71
Role of Fusobacteria in the serrated pathway of colorectal carcinogenesis
Park, C. H., Han, D. S., Oh, Y., Lee, A.-R., Lee, Y.-R., & Eun, C. S. (2016) · Scientific Reports · doi:10.1038/srep25271 · Cited by 70
Kasper, S. H., Morell-Perez, C., Wyche, T. P., Sana, T. R., Lieberman, L. A., & Hett, E. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-62139-z · Cited by 70
Gao, Y., Zou, T., Xu, P., Wang, Y., Jiang, Y., Chen, Y., Chen, H., Hong, J., & Fang, J. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100850 · Cited by 67
Gut mucosal microbiota profiles linked to colorectal cancer recurrence
Huo, R., Wang, Y., Hou, S., Wang, W., Zhang, C.-Z., & Wan, X. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i18.1946 · Cited by 69
Distinct intratumoral microbiome of young-onset and average-onset colorectal cancer
Barot, S. V., Sangwan, N., Nair, K. G., Schmit, S. L., Shao, X., Kamath, S. D., Liska, D., & Khorana, A. A. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.104980 · Cited by 65
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer
AIFEG, Sahnane, N., Magnoli, F., Bernasconi, B., Tibiletti, M. G., Romualdi, C., Pedroni, M., de Leòn, M. P., Magnani, G., Bonetti, L. R., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0165-2 · Cited by 65
Fusobacterium nucleatum: ecology, pathogenesis and clinical implications
Jiang, S., Chen, Y., & Fang, J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01237-z · Cited by 76
Zhang, X., Zhu, X., Cao, Y., Fang, J., Hong, J., & Chen, H. (2019) · Cancer Medicine · doi:10.1002/cam4.1850 · Cited by 65
Self-citationInamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.006 · Cited by 63
Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation
Galaski, J., Shhadeh, A., Umaña, A., Yoo, C. C., Arpinati, L., Isaacson, B., Berhani, O., Singer, B. B., Slade, D. J., Bachrach, G., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.692544 · Cited by 63
Nie, F., Zhang, J., Tian, H., Zhao, J., Gong, P., Wang, H., Wang, S., Yang, P., & Yang, C. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06640-7 · Cited by 68
The effect of periodontal bacteria infection on incidence and prognosis of cancer
Li, X., Zhang, Q., Peng, Y., Wang, D., & Liu, Y. (2020) · Medicine · doi:10.1097/md.0000000000019698 · Cited by 66
Wang, Q., Ye, J., Fang, D., Lv, L., Wu, W., Shi, D., Li, Y., Yang, L., Bian, X., Wu, J., et al. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01762-2 · Cited by 65
Tumor-Associated Microbiome: Where Do We Stand?
Oliva, M., Mulet-Margalef, N., Ochoa-de-Olza, M., Napoli, S., Mas-Lloret, J., Laquente, B., Alemany, L., Duell, E. J., Nuciforo, P. G., & Moreno, V. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031446 · Cited by 63
Huyghe, N. D., Benidovskaya, E., Stevens, P., & den Eynde, M. V. (2022) · Cancers · doi:10.3390/cancers14092241 · Cited by 65
Wang, X., Chen, Q., Zhu, Y., Wang, K., Chang, Y., Wu, X., Bao, W., Cao, T., Chen, H., Zhang, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01491-8 · Cited by 64
AtopobiumandFusobacteriumas novel candidates for sarcoidosis-associated microbiota
Zimmermann, A., Knecht, H., Häsler, R., Zissel, G., Gaede, K. I., Hofmann, S., Nebel, A., Müller–Quernheim, J., Schreiber, S., & Fischer, A. (2017) · European Respiratory Journal · doi:10.1183/13993003.00746-2016 · Cited by 67
Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Repass, J. F., Reproducibility Project: Cancer Biology, Iorns, E. J., Denis, A., Williams, S. R., Perfito, N., & Errington, T. M. (2018) · eLife · doi:10.7554/elife.25801 · Cited by 63
Borelli, B., Antoniotti, C., Carullo, M., Germani, M. M., Conca, V., & Masi, G. (2022) · Cancers · doi:10.3390/cancers14204974 · Cited by 62
Li, X., Huang, J., Yu, T., Fang, X., Lou, L., Xin, S., Ji, L., Jiang, F., & Lou, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.545251 · Cited by 62
Dadgar-Zankbar, L., Elahi, Z., Shariati, A., Khaledi, A., Razavi, S., & Khoshbayan, A. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01909-y · Cited by 68
Oh, H. J., Kim, J. H., Bae, J. M., Kim, H. J., Cho, N., & Kang, G. H. (2018) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2018.11.29 · Cited by 63
de Carvalho, A. C., Pereira, L. D. M., Datorre, J. G., dos Santos, W., Berardinelli, G. N., Matsushita, M., de Oliveira, M. A., Durães, R. O., Guimarães, D. P., & Reis, R. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00813 · Cited by 64
Pu, L. Z. C. T., Yamamoto, K., Honda, T., Nakamura, M., Yamamura, T., Hattori, S., Burt, A. D., Singh, R., Hirooka, Y., & Fujishiro, M. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14868 · Cited by 61
Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer
Gao, R., Zhu, Y., Kong, C., Xia, K., Li, H., Zhu, Y., Zhang, X., Liu, Y., Zhong, H., Yang, R., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.657867 · Cited by 66
Lee, J. A., Yoo, S.-Y., Oh, H. J., Jeong, S., Cho, N.-Y., Kang, G. H., & Kim, J. H. (2021) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-020-02657-x · Cited by 61
Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer
Yamamoto, S., Kinugasa, H., Hirai, M., Terasawa, H., Yasutomi, E., Oka, S., Ohmori, M., Yamasaki, Y., Inokuchi, T., Harada, K., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15361 · Cited by 60
Bautista, J., Maceiras, M. L., Hidalgo‐Tinoco, C., Guerra-Guerrero, A., Betancourt-Velarde, A., & López‐Cortés, A. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00883-8 · Cited by 74
The Salivary Microbiome and Oral Cancer Risk: A Pilot Study in Fanconi Anemia
Furquim, C. P., Soares, G. M. S., Ribeiro, L. L., Azcárate-Peril, M. A., Butz, N., Roach, J. M., MOSS, K. L., Bonfim, C., Torres‐Pereira, C. C., & Teles, F. (2016) · Journal of Dental Research · doi:10.1177/0022034516678169 · Cited by 60
Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients
Kunzmann, A. T., Proença, M. A., Jordão, H. W. T., Jirásková, K., Schneiderová, M., Levý, M., Liška, V., Büchler, T., Vodičková, Ľ., Vymetalkova, V. P., et al. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03649-1 · Cited by 61
Crosstalk between autophagy and microbiota in cancer progression
Wang, Y., Du, J., Wu, X., Abdelrehem, A., Ren, Y., Liu, C., Zhou, X., & Wang, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01461-0 · Cited by 61
Chen, T., Li, Q., Zhang, X., Long, R., Wu, Y., Wu, J., & Fu, X. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.05.008 · Cited by 59
Pignatelli, P., Iezzi, L., Pennese, M., Raimondi, P., Cichella, A., Bondi, D., Grande, R., Cotellese, R., Bartolomeo, N. D., Innocenti, P., et al. (2021) · Cancers · doi:10.3390/cancers13051032 · Cited by 59
The intratumoral microbiome: Characterization methods and functional impact
Heymann, C. J. F., Bard, J., Heymann, M., Heymann, D., & Bobin‐Dubigeon, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.009 · Cited by 60
Intestinal Microbiota in Colorectal Cancer Surgery
Koliarakis, I., Athanasakis, E., Sgantzos, M. N., Mariolis-Sapsakos, T. D., Xynos, E., Chrysos, E., Souglakos, J., & Tsiaoussis, J. (2020) · Cancers · doi:10.3390/cancers12103011 · Cited by 63
Borozan, I., Zaidi, S. H., Harrison, T. A., Phipps, A. I., Zheng, J., Lee, S., Trinh, Q. M., Steinfelder, R. S., Adams, J., Banbury, B. L., et al. (2022) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0463 · Cited by 57
Self-citationCao, C., Yue, S., Lü, A., & Liang, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107321 · Cited by 64
The Human Microbiota and Prostate Cancer: Friend or Foe?
Massari, F., Mollica, V., Nunno, V. D., Gatto, L., Santoni, M., Scarpelli, M., Cimadamore, A., Antonio Lopez-beltran, B., Liang Cheng, C., Battelli, N., et al. (2019) · Cancers · doi:10.3390/cancers11040459 · Cited by 58
Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy
Ganesan, K., Guo, S., Fayyaz, S., Zhang, G., & Xu, B. (2019) · Cancers · doi:10.3390/cancers11101592 · Cited by 59
The relationship between gastrointestinal cancers and the microbiota
LaCourse, K. D., Johnston, C. D., & Bullman, S. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30362-9 · Cited by 58
Self-citationEmerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
Dai, J.-H., Tan, X.-R., Qiao, H., & Liu, N. (2023) · Protein & Cell · doi:10.1093/procel/pwad052 · Cited by 57
Udayasuryan, B., Zhou, Z., Ahmad, R. N., Sobol, P., Deng, C., Nguyen, T. T. D., Kodikalla, S., Morrison, R. G., Goswami, I., Slade, D. J., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06201-w · Cited by 59
Fusobacterium�nucleatum promotes the progression of colorectal cancer by interacting with E‑cadherin
Ma, C., Luo, H., Gao, F., Tang, Q., & Chen, W. (2018) · Oncology Letters · doi:10.3892/ol.2018.8947 · Cited by 56
Role of the intestinal microbiome in colorectal cancer surgery outcomes
Lauka, L., Reitano, E., Carra, M. C., Gaiani, F., Gavriilidis, P., Brunetti, F., de’Angelis, G. L., Sobhani, I., & de’Angelis, N. (2019) · World Journal of Surgical Oncology · doi:10.1186/s12957-019-1754-x · Cited by 60
Pro-biomics: Omics Technologies To Unravel the Role of Probiotics in Health and Disease
Kiousi, D. E., Rathosi, M., Tsifintaris, M., Chondrou, P., & Galanis, Α. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab014 · Cited by 59
Vonaesch, P., Araújo, J. R., Gody, J., Mbecko, J., Sanke‐Waîgana, H., Andrianonimiadana, L., Naharimanananirina, T., Ningatoloum, S. N., Vondo, S. S., Gondje, P. B., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209589119 · Cited by 55
Kim, H. S., Kim, C. G., Kim, W. K., Kim, K., Yoo, J., Min, B. S., Paik, S., Shin, S. J., Lee, H., Lee, K., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1101291 · Cited by 55
Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer
Queen, J., Cing, Z., Minsky, H., Nandi, A., Southward, T., Ferri, J., McMann, M., Iyadorai, T., Vadivelu, J., Roslani, A. C., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00717-7 · Cited by 62
Gagnière, J., Bonnin, V., Jarrousse, A., Cardamone, E., Agus, A., Uhrhammer, N. A., Sauvanet, P., Déchelotte, P., Barnich, N., Bonnet, R., et al. (2017) · Clinical Science · doi:10.1042/cs20160876 · Cited by 62
Lehr, K., Nikitina, D., Vilchez-Vargas, R., Steponaitiene, R., Thon, C., Skieceviciene, J., Schanze, D., Zenker, M., Malfertheiner, P., Kupcinskas, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-31740-3 · Cited by 54
The Tumor Microenvironment of Colorectal Cancer Metastases: Opportunities in Cancer Immunotherapy
Kamal, Y., Schmit, S. L., Frost, H. R., & Amos, C. I. (2020) · Immunotherapy · doi:10.2217/imt-2020-0026 · Cited by 56
Characterization of the gut microbiome in epidemiologic studies: the multiethnic cohort experience
Fu, B. C., Randolph, T. W., Lim, U., Monroe, K. R., Cheng, I. C., Wilkens, L. R., Marchand, L. L., Hullar, M. A. J., & Lampe, J. W. (2016) · Annals of Epidemiology · doi:10.1016/j.annepidem.2016.02.009 · Cited by 58
A systematic review of microbial markers for risk prediction of colorectal neoplasia
Yu, L., Zhao, G., Wang, L., Zhou, X., Sun, J., Li, X., He, Y., He, Y., Kofonikolas, K., Bogaert, D., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01740-7 · Cited by 53
Fusobacterium nucleatum and Colorectal Cancer
Li, R., Shen, J., & Xu, Y. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s357922 · Cited by 56
The Pivotal Role of DNA Repair in Infection Mediated-Inflammation and Cancer
Sahan, A. Z., Hazra, T. K., & Das, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00663 · Cited by 56
Colorectal Cancer in the Adolescent and Young Adult Population
You, Y. N., Lee, L. D., Deschner, B. W., & Shibata, D. (2020) · JCO Oncology Practice · doi:10.1200/jop.19.00153 · Cited by 55
The Gum–Gut Axis: Periodontitis and the Risk of Gastrointestinal Cancers
Baima, G., Ribaldone, D. G., Romano, F., Aimetti, M., & Romandini, M. (2023) · Cancers · doi:10.3390/cancers15184594 · Cited by 55
Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms
Amitay, E. L., Krilavičiūtė, A., & Brenner, H. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1445957 · Cited by 56
Mima, K., Kosumi, K., Baba, Y., Hamada, T., Baba, H., & Ogino, S. (2020) · Human Genetics · doi:10.1007/s00439-020-02235-2 · Cited by 51
Self-citationHsieh, Y., Tung, S., Pan, H.-Y., Chang, T., Wei, K., Chen, W., Deng, Y.-F., Lu, C.-K., Lai, Y., Wu, C., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i42.7311 · Cited by 50
Ohara, T., & Mori, T. (2019) · Anticancer Research · doi:10.21873/anticanres.13647 · Cited by 51
Zhao, F., An, R., Ma, Y., Yu, S., Gao, Y., Wang, Y., Yu, H., Xie, X., & Zhang, J. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70273 · Cited by 50
Koi, M., Tseng-Rogenski, S. S., & Carethers, J. M. (2018) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v10.i1.1 · Cited by 52
Jordão, H. W. T., McKenna, G. J., McMenamin, Ú. C., Kunzmann, A. T., Murray, L., & Coleman, H. G. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619858043 · Cited by 50
Review article: bacteriophages in gastroenterology—from biology to clinical applications
Sabino, J., Hirten, R. P., & Colombel, J. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15557 · Cited by 53
Harness the functions of gut microbiome in tumorigenesis for cancer treatment
Lee, M. (2021) · Cancer Communications · doi:10.1002/cac2.12200 · Cited by 50
Bartolini, I., Risaliti, M., Ringressi, M. N., Melli, F., Nannini, G., Amedei, A., Muiesan, P., & Taddei, A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i20.2498 · Cited by 54
Wu, N., Feng, Y., Lyu, N., Wang, D., Yu, W., & Hu, Y. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i18.1981 · Cited by 49
Nanocatalytic bacteria disintegration reverses immunosuppression of colorectal cancer
Jiang, H., Guo, Y., Yu, Z., Hu, P., & Shi, J. (2022) · National Science Review · doi:10.1093/nsr/nwac169 · Cited by 49
Younginger, B. S., Mayba, O., Reeder, J., Nagarkar, D. R., Modrusan, Z. D., Albert, M. L., & Byrd, A. L. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100920 · Cited by 48
Gut Microbiota and Colorectal Cancer: A Balance Between Risk and Protection
Ionescu, V. A., Diaconu, C. C., Gheorghe, G., Mihai, M.-M., Diaconu, C. C., Bostan, M., & Bleoţu, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083733 · Cited by 55
Bacterial biofilms as a potential contributor to mucinous colorectal cancer formation
Li, S., Peppelenbosch, M. P., & Smits, R. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.009 · Cited by 49
Bacterial Translocation in Gastrointestinal Cancers and Cancer Treatment
Kouzu, K., Tsujimoto, H., Kishi, Y., Ueno, H., & Shinomiya, N. (2022) · Biomedicines · doi:10.3390/biomedicines10020380 · Cited by 49
The intratumor microbiome is associated with microsatellite instability
Byrd, D. A., Fan, W., Greathouse, K. L., Wu, M. C., Xie, H., & Wang, X. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad083 · Cited by 49
Mukherjee, S., Chopra, A., Karmakar, S., & Bhat, G. S. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2339260 · Cited by 54
The Role of the Gut Microbiome in Colorectal Cancer
Chen, G. (2018) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0037-1602239 · Cited by 49
Kim, S. H., & Lim, Y. J. (2021) · Intestinal Research · doi:10.5217/ir.2021.00034 · Cited by 47
Airway Fusobacterium is Associated with Poor Response to Immunotherapy in Lung Cancer
Chu, S., Cheng, Z., Yin, Z., Xu, J., Wu, F., Jin, Y., & Yang, G. (2022) · OncoTargets and Therapy · doi:10.2147/ott.s348382 · Cited by 48
Microbiota in cancer: current understandings and future perspectives
Yao, Y., Zhu, Y., Chen, K., Chen, J., Li, Y., Li, D., & Wei, P. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02335-3 · Cited by 56
Microbial Interactions and Interventions in Colorectal Cancer
Raay, T. J. V., & Allen‐Vercoe, E. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0004-2016 · Cited by 49
González‐Sarrías, A., Núñez‐Sánchez, M. Á., Ávila‐Gálvez, M. Á., Monedero‐Saiz, T., Rodríguez‐Gil, F. J., Martínez‐Díaz, F., Selma, M. V., & Espı́n, J. C. (2018) · Food & Function · doi:10.1039/c8fo00264a · Cited by 46
Progress in characterizing the linkage between Fusobacterium nucleatum and gastrointestinal cancer
Liu, Y., Baba, Y., Ishimoto, T., Iwatsuki, M., Hiyoshi, Y., Miyamoto, Y., Yoshida, N., Wu, R., & Baba, H. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1512-9 · Cited by 47
Self-citationBeyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics
Ferrara, F., Zoupanou, S., Primiceri, E., Ali, Z., & Chiriacò, M. S. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113698 · Cited by 46
The pathogenic oral–gut–liver axis: new understandings and clinical implications
Imai, J., Kitamoto, S., & Kamada, N. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1935877 · Cited by 46
Lu, S., Wang, C., Ma, J., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1456030 · Cited by 49
Fusobacterium in the microbiome: from health to disease across the oral–gut axis and beyond
Li, Z., Liu, J., Li, J., Zhou, Z., Huang, X., Gopinath, D., Luo, P., Wang, Q., & Shan, D. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00838-z · Cited by 47
Song, M., & Chan, A. T. (2017) · Current Colorectal Cancer Reports · doi:10.1007/s11888-017-0389-y · Cited by 50
Self-citationRole of Inflammation in Pathophysiology of Colonic Disease: An Update
Nasef, N. A., & Mehta, S. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134748 · Cited by 47
Hsueh, C., Lau, H., Huang, Q., Gong, H., Sun, J., Cao, P., Hu, C., Zhang, M., Tao, L., & Zhou, L. F. (2022) · Cancer · doi:10.1002/cncr.34338 · Cited by 45
Influence of the microbiota on epigenetics in colorectal cancer
Sun, D., Chen, Y., & Fang, J. (2018) · National Science Review · doi:10.1093/nsr/nwy160 · Cited by 45
The Four Horsemen in Colon Cancer
Hernández-Luna, M. A., López-Briones, S., & Lurı́a-Pérez, R. (2019) · Journal of Oncology · doi:10.1155/2019/5636272 · Cited by 45
Okita, Y., Koi, M., Takeda, K., Ross, R. D., Mukherjee, B., Koeppe, E. S., Stoffel, E. M., Galanko, J. A., McCoy, A. N., Keku, T. O., et al. (2020) · Gut Pathogens · doi:10.1186/s13099-020-00384-3 · Cited by 44
Metadata
- Authors
- Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., Kostic, A. D., Giannakis, M., Bullman, S., Milner, D. A., Baba, H., Giovannucci, E. L., Garraway, L. A., Freeman, G. J., Dranoff, G., Garrett, W. S., Huttenhower, C., Meyerson, M., Meyerhardt, J. A., Chan, A. T., Fuchs, C. S., & Ogino, S.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Kumamoto University (JP)
- Corresponding author
- Ogino, Shuji
- ORCID
- Mima, Kosuke
- Nishihara, Reiko
- Qian, Zhi Rong
- Cao, Yin
- Sukawa, Yasutaka
- Nowak, Jonathan A
- Yang, Juhong
- Dou, Ruoxu
- Masugi, Yohei
- Song, Mingyang
- Kostic, Aleksandar D
- Giannakis, Marios
- Bullman, Susan
- Milner, Danny A
- Baba, Hideo
- Giovannucci, Edward L
- Garraway, Levi A
- Freeman, Gordon J
- Dranoff, Glenn
- Garrett, Wendy S
- Huttenhower, Curtis
- Meyerson, Matthew
- Meyerhardt, Jeffrey A
- Chan, Andrew T
- Fuchs, Charles S
- Ogino, Shuji
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-08-26
- Volume
- 65
- Issue
- 12
- Pages
- 1973-1980
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC4769120
- OpenAlex
- W2199896469
- Cited by
- 1,080
- References
- 53
- Citations by year
- 2026: 108 · 2025: 116 · 2024: 131 · 2023: 119 · 2022: 141 · 2021: 140 · 2020: 105 · 2019: 71 · 2018: 64 · 2017: 47 · 2016: 34 · 2015: 4
- FWCI
- 21.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (KL2TR001100)
- National Cancer Institute (P50CA127003, R01CA151993, R01CA118553, R01CA137178, R35CA197735, P01CA087969, R01CA169141, K07CA122826, P01CA055075, UM1CA186107, UM1CA167552, K07CA190673, R01CA154426)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK098311)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Fusobacterium nucleatum, colorectal cancer, rectal cancer, colon cancer, prognosis, colorectal cancer-specific mortality, tumor microbiome, microsatellite instability, CpG island methylator phenotype, BRAF mutation, prognostic factors, gut microbiota, antitumor immunity
- MeSH terms
- Aged, Carcinoma, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mutation, Neoplasm Staging, Phenotype, Prognosis, Prospective Studies, Research Design, Biomarkers, Tumor, Colorectal Neoplasms, Databases, Factual, Proto-Oncogene Proteins p21(ras), Fusobacterium nucleatum, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins B-raf, Kaplan-Meier Estimate, Microsatellite Instability, Class I Phosphatidylinositol 3-Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
